Filing Details
- Accession Number:
- 0001209191-17-008073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-06 17:23:11
- Reporting Period:
- 2017-02-03
- Filing Date:
- 2017-02-06
- Accepted Time:
- 2017-02-06 17:23:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 264106690 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1587788 | Jay Shepard | C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-02-03 | 6,719 | $13.69 | 213,858 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to 10b5-1 plan.
- The shares were sold at prices ranging from $13.35 to $14.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.